Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Mar 6;284(6317):689–693. doi: 10.1136/bmj.284.6317.689

Captopril in renovascular hypertension: long-term use in predicting surgical outcome.

A B Atkinson, J J Brown, A M Cumming, R Fraser, A F Lever, B J Leckie, J J Morton, J I Robertson
PMCID: PMC1496684  PMID: 6802290

Abstract

The angiotensin converting-enzyme inhibitor captopril was used as long-term preoperative treatment in a series of hypertensive patients with unilateral renal arterial disease. There were immediate and sustained falls in plasma angiotensin II and aldosterone concentrations, with converse increases in circulating renin and angiotensin I. In patients with sodium and potassium deficiency and secondary aldosterone excess before treatment captopril corrected the sodium and potassium deficits; in these cases the initial hypotensive response was profound but the later effect was less pronounced. When sodium and potassium state was initially normal it remained unchanged during captopril treatment, while the full hypotensive effect took up to three weeks to be attained. The immediate, but not long-term, falls in arterial pressure with captopril were proportional to the immediate decrements of plasma angiotensin II. Nevertheless, while the immediate blood-pressure reduction with captopril variously overestimated and underestimated the eventual surgical response, the absolute blood-pressure values during long-term captopril related well with those after operation. Pretreatment plasma renin and angiotensin II concentrations, while closely predicting the immediate captopril response, are fallible guides to surgical prognosis. In contrast, long-term treatment with converting-enzyme inhibitors may provide an accurate indication of surgical outcome.

Full text

PDF
690

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson G. H., Jr, Springer J., Randall P., Streeten D. H., Blakeman N. Effect of age on diagnostic usefulness of stimulated plasma renin activity and saralasin test in detection of renovascular hypertension. Lancet. 1980 Oct 18;2(8199):821–824. doi: 10.1016/s0140-6736(80)90172-5. [DOI] [PubMed] [Google Scholar]
  2. Atkinson A. B., Brown J. J., Davies D. L., Leckie B., Lever A. F., Morton J. J., Robertson J. I. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery. Hypertension. 1981 Jan-Feb;3(1):53–58. doi: 10.1161/01.hyp.3.1.53. [DOI] [PubMed] [Google Scholar]
  3. Atkinson A. B., Brown J. J., Lever A. F., McAreavey D., Robertson J. I., Behan P. O., Melville I. D., Weir A. I. Neurological dysfunction in two patients receiving captopril and cimetidine. Lancet. 1980 Jul 5;2(8184):36–37. doi: 10.1016/s0140-6736(80)92912-8. [DOI] [PubMed] [Google Scholar]
  4. Atkinson A. B., Davies D. L., Leckie B., Morton J. J., Brown J. J., Fraser R., Lever A. F., Robertson J. I. Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet. 1979 Sep 22;2(8143):606–609. doi: 10.1016/s0140-6736(79)91666-0. [DOI] [PubMed] [Google Scholar]
  5. Atkinson A. B., Morton J. J., Brown J. J., Davies D. L., Fraser R., Kelly P., Leckie B., Lever A. F., Robertson J. I. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Br Heart J. 1980 Sep;44(3):290–296. doi: 10.1136/hrt.44.3.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Atkinson A. B., Robertson J. I. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet. 1979 Oct 20;2(8147):836–839. doi: 10.1016/s0140-6736(79)92186-x. [DOI] [PubMed] [Google Scholar]
  7. Atlas S. A., Case D. B., Sealey J. E., Laragh J. H., McKinstry D. N. Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis. Hypertension. 1979 May-Jun;1(3):274–280. doi: 10.1161/01.hyp.1.3.274. [DOI] [PubMed] [Google Scholar]
  8. BERLYNE G. M., TAVILL A. S., DE BAKER S. B. RENAL ARTERY STENOSIS AND THE NEPHROTIC SYNDROME. Q J Med. 1964 Jul;33:325–335. [PubMed] [Google Scholar]
  9. BROWN J. J., MATTHEW G. K., ROBERTSON J. I. THE EFFECT OF ANGIOTENSIN ON THE FUNCTION OF THE SEPARATE KIDNEYS IN PATIENTS WITH UNILATERAL RENAL ARTERY STENOSIS. Clin Sci. 1964 Jun;26:381–395. [PubMed] [Google Scholar]
  10. BROWN J. J., PEART W. S. The effect of angiotension on urine flow and electrolyte excretion in hypertensive patients. Clin Sci. 1962 Feb;22:1–17. [PubMed] [Google Scholar]
  11. Bean B. L., Brown J. J., Casals-Stenzel J., Fraser R., Lever A. F., Millar J. A., Morton J. J., Petch B., Riegger A. J., Robertson J. I. The relation of arterial pressure and plasma angiotensin II concentration. A change produced by prolonged infusion of angiotensin II in the conscious dog. Circ Res. 1979 Apr;44(4):452–458. doi: 10.1161/01.res.44.4.452. [DOI] [PubMed] [Google Scholar]
  12. Bianchi G., Baldoli E., Lucca R., Barbin P. Pathogenesis of arterial hypertension after the constriction of the renal artery leaving the opposite kidney intact both in the anaesthetized and in the conscious dog. Clin Sci. 1972 Jun;42(6):651–664. doi: 10.1042/cs0420651. [DOI] [PubMed] [Google Scholar]
  13. Boddy K., King P. C., Tothill P., Strong J. A. Measurement of total body potassium with a shadow shield whole-body counter: calibration and errors. Phys Med Biol. 1971 Apr;16(2):275–282. doi: 10.1088/0031-9155/16/2/310. [DOI] [PubMed] [Google Scholar]
  14. Brown J. J., Casals-Stenzel J., Cumming A. M., Davies D. L., Fraser R., Lever A. F., Morton J. J., Semple P. F., Tree M., Robertson J. I. Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture. Hypertension. 1979 May-Jun;1(3):159–179. doi: 10.1161/01.hyp.1.3.159. [DOI] [PubMed] [Google Scholar]
  15. Brown J. J., Davies D. L., Morton J. J., Robertson J. I., Cuesta V., Lever A. F., Padfield P. L., Trust P. Mechanism of renal hypertension. Lancet. 1976 Jun 5;1(7971):1219–1221. doi: 10.1016/s0140-6736(76)92165-6. [DOI] [PubMed] [Google Scholar]
  16. Brown J. J., Lever A. F., Davies D. L., Robertson J. I. Renin and angiotensin. A survey of some aspects. Postgrad Med J. 1966 Mar;42(485):153–176. doi: 10.1136/pgmj.42.485.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Caravaggi A. M., Bianchi G., Brown J. J., Lever A. F., Morton J. J., Powell-Jackson J. D., Robertson J. I., Semple P. F. Blood pressure and plasma angiotensin II concentration after renal artery constriction and angiotensin infusion in the dog. (5-Isoleucine)angiotensin II and its breakdown fragments in dog blood. Circ Res. 1976 Apr;38(4):315–321. doi: 10.1161/01.res.38.4.315. [DOI] [PubMed] [Google Scholar]
  18. Case D. B., Atlas S. A., Laragh J. H., Sealey J. E., Sullivan P. A., McKinstry D. N. Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis. 1978 Nov-Dec;21(3):195–206. doi: 10.1016/0033-0620(78)90025-7. [DOI] [PubMed] [Google Scholar]
  19. Davies D. L., Robertson J. W. Simultaneous measurement of total exchangeable potassium and sodium using 43 K and 24 Na. Metabolism. 1973 Feb;22(2):133–137. doi: 10.1016/0026-0495(73)90263-1. [DOI] [PubMed] [Google Scholar]
  20. Dickinson C. J., Yu R. Mechanisms involved in the progressive pressor response to very small amounts of angiotensin in conscious rabbits. Circ Res. 1967 Jul;21(1 Suppl):157+–157+. [PubMed] [Google Scholar]
  21. Düsterdieck G., McElwee G. Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states. Eur J Clin Invest. 1971 Nov;2(1):32–38. doi: 10.1111/j.1365-2362.1971.tb00565.x. [DOI] [PubMed] [Google Scholar]
  22. Fraser R., Guest S., Young J. A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man. Clin Sci Mol Med. 1973 Sep;45(3):411–415. doi: 10.1042/cs0450411. [DOI] [PubMed] [Google Scholar]
  23. Grim C. E., Luft F. C., Weinberger M. H., Grim C. M. Sensitivity and specificity of screening tests for renal vascular hypertension. Ann Intern Med. 1979 Oct;91(4):617–622. doi: 10.7326/0003-4819-91-4-617. [DOI] [PubMed] [Google Scholar]
  24. Heel R. C., Brogden R. N., Speight T. M., Avery G. S. Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs. 1980 Dec;20(6):409–452. doi: 10.2165/00003495-198020060-00001. [DOI] [PubMed] [Google Scholar]
  25. Mackay A., Eadie A. S., Cumming A. M., Graham A. G., Adams F. G., Horton P. W. Assessment of total and divided renal plasma flow by 123I-hippuran renography. Kidney Int. 1981 Jan;19(1):49–57. doi: 10.1038/ki.1981.6. [DOI] [PubMed] [Google Scholar]
  26. Marks L. S., Maxwell M. H., Kaufman J. J. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension. Ann Intern Med. 1977 Aug;87(2):176–182. doi: 10.7326/0003-4819-87-2-176. [DOI] [PubMed] [Google Scholar]
  27. SELKURT E. E. Effect of pulse pressure and mean arterial pressure modification on renal hemodynamics and electrolyte and water excretion. Circulation. 1951 Oct;4(4):541–551. doi: 10.1161/01.cir.4.4.541. [DOI] [PubMed] [Google Scholar]
  28. Thomas R. D., Ball S. G., Lee M. R. Failure of saralasin to predict a response to surgery in renovascular hypertension. Lancet. 1977 Apr 2;1(8014):724–726. doi: 10.1016/s0140-6736(77)92168-7. [DOI] [PubMed] [Google Scholar]
  29. Waite M. A. Measurement of concentrations of angiotensin I in human blood by radioimmunoassay. Clin Sci. 1973 Jul;45(1):51–64. doi: 10.1042/cs0450051. [DOI] [PubMed] [Google Scholar]
  30. Wilson H. M., Wilson J. P., Slaton P. E., Foster J. H., Liddle G. W., Hollifield J. W. Saralasin infusion in the recognition of renovascular hypertension. Ann Intern Med. 1977 Jul;87(1):36–42. doi: 10.7326/0003-4819-87-1-36. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES